News

View: 

Joep Lange will be greatly missed

18 July 2014 |
We were deeply saddened to learn that HIV pioneer Joep Lange died in the aircrash above Ukraine on 17 July. Joep Lange was a member of the Foundation’s Advisory Committee. He was one of the earliest supporters of the Access to Medicine Foundation, and remained always ready to lend his strength and advice. His commitment to improving global health was almost unmatched.› Read more

2014 Index: point-by-point analysis begins

17 June 2014 |
The analysis at the heart of the 2014 Access to Medicine Index has begun: the Index team is now conducting a point-by-point comparison of companies’ performances, policies and practices for improving access to medicine.› Read more

Data-collection update: clarification has begun

9 April 2014 |
Data-collection for the 2014 Access to Medicine Index has entered the next stage: following a detailed evaluation of the data by the analysts, the 21 pharmaceutical companies have started clarifying and supplementing their information. Head of Research, Jayasree K. Iyer explains further.› Read more

R&D for TB: medicines against drug-resistant TB is the main focus for big pharma

22 March 2014 |
Nine million people suffer from TB, and three million TB patients have no access to treatment. For World TB Day, the Access to Medicine Index analysed data from the 2012 Index and public sources to see where the 20 largest pharmaceutical companies are focusing their clinical-trial efforts to tackle this disease: on new TB vaccines and drugs, and on drug-resistant strains of TB.› Read more

Access to Medicine Index in world's 3 most credible sustainability ratings

18 February 2014 |
In the 2013 Polling the Experts survey by GlobeScan/SustainAbility, experts have placed the Access to Medicine Index in the three most credible sustainability ratings worldwide.› Read more

The Lancet Global Health publishes longitudinal analysis

31 January 2014 |
In a letter published today in The Lancet Global Health, Professor Hans Hogerzeil and members of the Foundation's Research Team set out the method and findings of the first longitudinal analysis based on the Access to Medicine Index.› Read more

Ten years on, the role for the Index continues to grow

28 January 2014 |
It is ten years since work began on the first Access to Medicine Index. To mark this milestone, the Foundation brought together many of the people who helped make the Index a reality. Held on 23 January, the event provided a timely opportunity to assess the path ahead for the Index.› Read more

Data collection starts for the 2014 Access to Medicine Index

13 January 2014 |
Today marks the start of the data collection process for the 2014 Access to Medicine Index. Over the next few months, pharmaceutical companies will submit their data using our online platform, which is set up to ensure that the data is as concise, relevant and of the highest quality possible.› Read more

Seasons Greetings!

17 December 2013 |
A lively year of engagement with various stakeholders has passed, leading to our revised methodology and a fresh eye on 2014. We now turn our focus to the 2014 Access to Medicine Index, preparing for data submission by the 21 companies, as well developing other features of the Index.› Read more

Access to Medicine Index places more emphasis on how well pharmaceutical companies respond to patient needs

12 November 2013 |
- Refined methodology to measure Big Pharma's initiatives in more countries for more diseases -› Read more

Sustainalytics named 2014 Access to Medicine Index Research Partner

1 October 2013 |
The Access to Medicine Foundation has selected Sustainalytics as its research partner for the 2014 Access to Medicine Index. Following a competitive tender process, Sustainalytics emerged as the top candidate due to the firm’s expertise in environmental, social and governance (ESG) research and analysis and its dedicated pharmaceutical industry analysts.› Read more

New England Journal of Medicine publishes Index Perspective article

5 September 2013 |
Today, the New England Journal of Medicine is publishing a Perspective article written by Hans Hogerzeil. The article sets out the methods of the Access to Medicine Index, touching upon the 2012 Index’ key findings and trends.› Read more

BNP Paribas becomes newest Index signatory investor

13 August 2013 |
BNP Paribas Investment Partners, one of Europe’s largest investment groups with €503 billion in assets under management and advice, is the latest addition to the group of investors supporting the Access to Medicine Index.› Read more

Experts define opportunities for collaboration and measurement in Accra

9 July 2013 |
On June 25th and 26th, 2013, 18 key access to medicine experts met with senior managers and researchers from the Access to Medicine Foundation in Accra, Ghana, to jointly discuss important aspects of the balance between affordability, quality and safety of medicines in Africa and other parts of the developing world.› Read more

Expert Review Committee meets to discuss Index methodology

10 June 2013 |
Each Index cycle we fine-tune the methodology based on stakeholder feedback and input from experts.› Read more

Ghana meeting to address affordability and quality of medicine

12 June 2013 |
How can pharmaceutical companies work with various stakeholders involved in ensuring functioning health systems in developing countries to provide affordable medicine for the people who need it most? And how can they better partner with national and regional players to support the strengthening of national pharmacovigilance systems?› Read more

Pharma eager to make access work in practice

3 June 2013 |
On 7 May, high-level representatives from the top 20 pharmaceutical companies covered in the Index came together in a Strategic Access to Medicine Workshop. Hosted by the Access to Medicine Foundation team and facilitated by Sophia Tickell and Becky Buell from Meteos, the workshop took place in a constructive atmosphere and clearly revealed that the industry is open to more collaboration.› Read more

New Expert Review Committee to meet in June

24 May 2013 |
On June 6th, the Expert Review Committee (ERC) for the 2014 Access to Medicine Index will gather to work on the next Index methodology. This committee is comprised of renowned experts representing various stakeholder groups, and their contributions will ensure that the methodology for the upcoming Index is as balanced and robust as possible.› Read more

Foundation brings companies together to discuss access strategies

3 May 2013 |
On May 7th, 2013, the Access to Medicine Foundation will host a Strategic Access to Medicine Workshop for high-level representatives from the top 20 pharmaceutical companies covered in the Access to Medicine Index.› Read more

2013: Focus on methodology

10 April 2013 |
After the launch of the 2012 Access to Medicine Index in November 2012, the Foundation officially entered a new ‘Index cycle’, the two-year process culminating in the publication of the next Access to Medicine Index.› Read more

Open invitation for feedback: 2012 Access to Medicine Index

12 February 2013 |
The Access to Medicine Foundation invites you to share your thoughts about the 2012 Access to Medicine Index in our short online survey. Because of the large amount of feedback we are still receiving, we have decided to extend the response deadline by one week to March 4th, 2013.› Read more

Foundation strengthens in-house research capacity

29 January 2013 |
In a drive to strengthen our in-house research capacity for the coming Access to Medicine Index cycles, the Foundation has recently appointed Jayasree Iyer as new Head of Research.› Read more

Global media coverage of the 2012 findings

18 December 2012 |
Since its launch on 28 November, a wide variety of media outlets have featured the 2012 Access to Medicine Index findings.› Read more

Top pharma investment analysts discuss 2012 Index

13 December 2012 |
On 6 and 12 December, the Foundation presented the 2012 Index findings to 50 top pharmaceutical analysts at three meetings, hosted by Goldman Sachs in London, Amundi Asset Management in Paris and our research partner MSCI ESG Research in New York.› Read more

Longer lives, shifting burdens

17 December 2012 |
Index researchers recently attended the Global Burden of Disease Study 2010 presentation and a conference hosted by DNDi, Médecins Sans Frontières, and Mt. Sinai School of Medicine on innovations in treating neglected patients and populations.The expertise gathered from these events will be considered when developing the methodology for the next Access to Medicine Index. › Read more

Media have their say on the 2012 Access to Medicine Index

28 November 2012 |
Various media outlets have reported on the findings of the 2012 Access to Medicine Index since its launch on 28 November. Examples of the coverage can be found in the links below and a full overview is available in our In the Media section.› Read more

Index to be published 28 November 2012

6 November 2012 |
The analysis is nearing completion and we are happy to announce that the 2012 Access to Medicine Index will be published on Wednesday, 28 November.› Read more

Increasing the robustness of the Index through expert review

2 November 2012 |
Analysing the data provided by the top 20 pharmaceutical companies, and cross-checking it with other sources involves a thorough process that takes at least two months. This year, to make the Index even more robust, we engaged some of the best experts in the field of global health to support the team in this process by providing technical review of the analysis.› Read more

Rate the Raters asks the experts

14 September 2012 |
In the latest Rate the Raters expert survey, the Access to Medicine Index is ranked among the top five raters with respect to credibility. A total of 850 sustainability experts from businesses, NGOs and academic institutions in 70 countries completed the survey, which evaluated rating systems measuring company performance in single or multiple facets of sustainability.› Read more

Gates Foundation and Dutch government extend financial support

10 September 2012 |
Over the next five years, the Access to Medicine Foundation will receive funding from the Bill & Melinda Gates Foundation and the Dutch Ministry of Foreign Affairs. These commitments follow the recent announcement of a four-year grant from the British Department for International Development.› Read more

Long-term support from DFID strengthens ATMF

7 June 2012 |
The UK Department for International Development will be funding the Access to Medicine Foundation in the coming four years. This will substantially strengthen the Foundation’s financial position.› Read more

Index 2012 - 80% submitted

1 June 2012 |
The data collection and initial analysis for the 2012 Index, scheduled for October 2012, is well underway. All of the companies have submitted their data on schedule, constituting already 80% of the data. The staggered approach to data collection will bring the remaining 20% by the end of the month. The MSCI analysts have begun preparing the data for scoring.› Read more

Maternal and Newborn Health now included in Methodology 2012

24 May 2012 |
Every two minutes, a woman dies of pregnancy-related complications such as severe bleeding, infections after childbirth or unsafe abortion. In addition, more than 4 out of 10 deaths in babies’ first week of life are due to neonatal infections.› Read more

Robyn Scott elected Young Global Leader 2012

21 May 2012 |
Robyn Scott, Ambassador for the Index since its launch, has been elected a World Economic Forum Young Global Leader 2012. The honour, bestowed each year by the Forum, recognises outstanding young leaders around the world for their professional accomplishments, commitment to society and potential to contribute to shaping the future of the world.› Read more

"Drug companies join forces to combat deadliest tropical diseases"

31 January 2012 |
The heads of 13 of the world's biggest drug companies, brought together by Bill Gates, have agreed to donate more medicines and, in a rare spirit of co-operation, to work together to find new ones in an attempt to end many neglected tropical diseases that kill and maim some› Read more

Leaders in dialogue about stakeholder value

26 January 2012 |
On the 29th of March, the third National Reputation Conference will take place in Amsterdam. Leaders from a broad range of sectors, such as finance, healthcare, education and energy will take part in a dialogue on how their companies can make a shift from shareholder value to the so-called stakeholder value.› Read more

Season’s greetings!

22 December 2011 |
The end of the year is quickly drawing near, which provides the perfect opportunity to briefly look back on our activities over the past few months. At the same time, we look forward to 2012, when the Access to Medicine Index 2012 will be the focus of our attention.› Read more

Index Team at ICIUM

10 November 2011 |
Turkey will be the venue for the 3rd ICIUM Conference, which will take place from 14-18 November. The Index team will be attending, contributing data and insights from the Access to Medicine Index 2010 on pharmaceutical companies’ contribution to improving medicine use.› Read more

Timelines for the Index 2012

4 November 2011 |
We are currently preparing our Access to Medicine Index 2012 and finalising the methodology. MSCI, leading player in ESG research and analysis, will again be our valued partner for the Index 2012. We are making steady progress and have set the first few important dates. Publication is planned for autumn 2012. A brief update of our progress is given below. › Read more

New Supervisory Board

27 October 2011 |
As of October 26, the strategic supervision of the Access to Medicine Foundation will be in the hands of a Supervisory Board, chaired by Sjoerd van Keulen. The international experience and expertise of the five board members will be crucial in supporting our increasingly global reach.› Read more

New Team Members

27 October 2011 |
The Access to Medicine Foundation team has recently been strengthened in the areas of Funding, Strategy, Operations and Research. Please join us in welcoming Ed, Conny, Samia and Niamh to our team!  › Read more

Accelerating Access to Medical Devices

6 October 2011 |
The Access to Medicine Index has already proven to encourage influential pharmaceutical companies to do more for the two billion people in the world who currently lack access to medicine. The Access to Medical Devices Ranking could do the same for the developers and manufacturers of medical devices.› Read more

TV Documentary 'Patents or Patients?'

20 July 2011 |
On 20 and 27 July, the Access to Medicine Index and Wim Leereveld, are featured in a Dutch documentary about access to medicine in developing countries. Gideon Levy, an award-winning reporter, investigates how it is possible that two billion people lack access to medicine.› Read more

Experts Meet for Index 2012

22 July 2011 |
On 22 July the new Expert Review Committee (ERC) met for the first time in Haarlem, to debate the methodology of next year’s Index. The issues on the agenda were raised through stakeholder consultation, which has been ongoing in the first half of 2011.  › Read more

Support from Minister Ben Knapen

29 June 2011 |
The Dutch Minister of European Affairs and International Cooperation, Ben Knapen, has given his full support to the work of the Access to Medicine Foundation. The Foundation is delighted with his endorsement and the continuing support of the Dutch government, one of our major funders. Below you will find his support quote:› Read more

Pharma Companies Meet with Index Team

18 July 2011 |
In May the Index team met with over 30 representatives of the pharmaceutical industry representing 15 of the companies ranked in the Index. The roundtable meeting held in the Netherlands, was a milestone for the Index team and a strong indication of the growing relevance of the Index for pharmaceutical companies.› Read more

First ATM Seminar in October

24 June 2011 |
From 5 - 7 October 2011 the first Access to Medicine Seminar will be held in the Netherlands. A hands-on and interactive session for participants from pharmaceutical companies, investors and public health professionals.› Read more

'GSK Makes a Good Impression with Lower Priced Vaccines'

13 June 2011 |
Was headlined in the Dutch daily newspaper 'De Volkskrant'. The article featured the recent announcements of pharmaceutical companies GSK, Merck and Sanofi-Aventis to lower their prices of vaccines in developing countries and the first time that UNICEF publicly listed the price it pays for vaccines.  The Access to Medicine Index, in the person of Wim Leereveld was asked to comment.› Read more

'Big Pharma Is Changing Under Pressure'

30 May 2011 |
On the 27th of May, 'De Volkskrant', a leading Dutch daily, reports on how pharmaceutical companies are challenged by the Access to Medicine Index to do more on access to medicine in the developing countries.› Read more

The Al Gore of the Pharmaceutical Industry?

26 May 2011 |
On May 24th, Harmke Pijpers of BNR - Business News Radio - interviewed Wim Leereveld about the Access to Medicine Index. Harmke introduced Wim to the audience as the 'Al Gore of the pharmaceutical industry', to illustrate the drive he still has after 8 years to encourage the world's largest pharma companies to do more for 2 billion people who lack access to medicine.› Read more

Pages

You are here